Harrow, Inc. (HROW)
47.32
+1.26
(+2.74%)
USD |
NASDAQ |
Feb 06, 16:00
47.00
-0.32
(-0.68%)
After-Hours: 20:00
Harrow SG&A Expense (TTM) : 144.39M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Assertio Holdings, Inc. | 63.52M |
| Skye Bioscience, Inc. | 16.93M |
| Theravance Biopharma, Inc. | 75.94M |
| Kyntra Bio, Inc. | 28.80M |